Keytruda 100mg/4ml (Pembrolizumab Vials) 100mg/4ml

Keytruda 100mg/4ml is a PD-1 immune checkpoint inhibitor used in the treatment of various cancers. It is indicated for the following conditions:

• Melanoma: Treatment of unresectable or metastatic melanoma.
• Non-small cell lung cancer: Treatment of metastatic non-small cell lung cancer with PD-L1 expression.
• Head and neck squamous cell carcinoma: Treatment of recurrent or metastatic head and neck squamous cell carcinoma with PD-L1 expression.
• Classical Hodgkin lymphoma: Treatment of relapsed or refractory classical Hodgkin lymphoma.
• Urothelial carcinoma: Treatment of locally advanced or metastatic urothelial carcinoma with PD-L1 expression.

• Pembrolizumab works by blocking the interaction between the PD-1 receptor on T cells and its ligands PD-L1/PD-L2. This inhibition enhances the anti-tumor immune response by preventing the suppression of T cells, allowing them to attack and destroy cancer cells more effectively.

Keytruda 100mg/4ml, like other cancer treatments, can cause side effects. Common side effects include fatigue, nausea, and skin reactions. Serious or rare side effects may include immune-mediated adverse reactions, such as pneumonitis, colitis, hepatitis, endocrinopathies, and nephritis. Patients should be monitored closely for signs of these serious side effects.

Common Side Effects

• Fatigue: Feeling tired or weak.
• Nausea: Feeling sick to the stomach.
• Skin reactions: Rash or itching.
• Diarrhea: Loose or watery stools.
• Decreased appetite: Loss of appetite.
• Constipation: Difficulty passing stools.

Serious or Rare Side Effects

• Pneumonitis: Inflammation of the lungs.
• Colitis: Inflammation of the colon.
• Hepatitis: Inflammation of the liver.
• Endocrinopathies: Hormonal disorders, such as hypothyroidism or hyperthyroidism.
• Nephritis: Inflammation of the kidneys.

Keytruda 100mg/4ml should be used with caution and under the supervision of a healthcare professional. Important precautions include:

• Pregnancy: Avoid use during pregnancy due to potential risks to the fetus.
• Breastfeeding: Avoid use during breastfeeding due to potential risks to the infant.
• Allergic reactions: Monitor for signs of allergic reactions, such as rash, itching, or difficulty breathing.
• Immune-mediated reactions: Monitor for signs of immune-mediated adverse reactions, such as pneumonitis, colitis, or hepatitis.
• Hepatic impairment: Monitor liver function regularly.
• Renal impairment: Monitor renal function regularly.
• Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Keytruda 100mg/4ml may interact with other medications, potentially affecting its efficacy or increasing the risk of side effects. Major and moderate interactions should be carefully considered.

Major Interactions (Avoid)

• Avoid concomitant use with other immune checkpoint inhibitors due to increased risk of immune-mediated adverse reactions.
• Avoid use with live vaccines due to potential for vaccine-related infections.
• Avoid use with other medications that suppress the immune system, such as corticosteroids, due to potential for reduced efficacy.

Moderate Interactions (Monitor Closely)

• Monitor closely when used with medications that affect liver function, such as certain antibiotics or antifungals.
• Monitor closely when used with medications that affect kidney function, such as certain NSAIDs or diuretics.
• Monitor closely when used with medications that affect the immune system, such as certain immunosuppressants.